Search -

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation ESC 2025

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Presenter: Milind Y Desai

August 30, 2025

Presentation TCT 2020

TCT 602: Bewildering Pseudoaneurysm: An Odyssey of Cover Stenting

Presenter: ROOPESH SINGHAL

October 14, 2020

Presentation ACC 2020

Alirocumab Efficacy And Safety In Adults With Homozygous Familial Hypercholesterolemia (ODYSSEY HoFH)

Presenter: Dirk J. Blom

March 30, 2020

Presentation JIM 2020

The TAVR Odyssey: From niche therapy to standard-of-care and beyond…

Presenter: Martin B. Leon

February 12, 2020

Presentation JIM 2020

The TAVR Odyssey: From Niche Therapy to Standard-of-Care

Presenter: Giuseppe Tarantini

February 12, 2020

Presentation TCT 2018

ACC 2018 Late Breaking Trial #1 - ODYSSEY Outcomes: What I Liked and What I Question

Presenter: Deepak L. Bhatt, Gregg W. Stone, Otavio Berwanger, Peter Juni, Sanjay Kaul, Roxana Mehran, E. Magnus Ohman, Stuart J. Pocock, Giulio Stefanini

September 23, 2018

Presentation TCT 2018

All-Cause Mortality and Interpretation of Secondary Endpoints: The VEST and ODYSSEY Examples

Presenter: E. Magnus Ohman, Stuart J. Pocock

September 23, 2018

Presentation ACC 2018

The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome

Presenter: Philippe Gabriel Steg

March 10, 2018

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2016

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Presenter: Michael C. John, Gregg W. Stone, Chuck Simonton

November 01, 2016

Presentation TCT 2013

The Odyssey of TAVR: From Concept to Clinical Reality

Presenter: Alain Cribier

October 30, 2013

Presentation TCT 2012

The Odyssey of Transcatheter Aortic Valve Replacement (TAVR): From Concept to Clinical Reality: A 10-Year Anniversary Celebration

Presenter: Martin Leon

October 26, 2012

Advertisement

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

TCT 602: Bewildering Pseudoaneurysm: An Odyssey of Cover Stenting

Alirocumab Efficacy And Safety In Adults With Homozygous Familial Hypercholesterolemia (ODYSSEY HoFH)

The TAVR Odyssey: From niche therapy to standard-of-care and beyond…

The TAVR Odyssey: From Niche Therapy to Standard-of-Care

ACC 2018 Late Breaking Trial #1 - ODYSSEY Outcomes: What I Liked and What I Question

All-Cause Mortality and Interpretation of Secondary Endpoints: The VEST and ODYSSEY Examples

The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

The Odyssey of TAVR: From Concept to Clinical Reality

The Odyssey of Transcatheter Aortic Valve Replacement (TAVR): From Concept to Clinical Reality: A 10-Year Anniversary Celebration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content